Cargando…

Florbetaben PET in the Early Diagnosis of Alzheimer's Disease: A Discrete Event Simulation to Explore Its Potential Value and Key Data Gaps

The growing understanding of the use of biomarkers in Alzheimer's disease (AD) may enable physicians to make more accurate and timely diagnoses. Florbetaben, a beta-amyloid tracer used with positron emission tomography (PET), is one of these diagnostic biomarkers. This analysis was undertaken t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Shien, Getsios, Denis, Hernandez, Luis, Cho, Kelly, Lawler, Elizabeth, Altincatal, Arman, Lanes, Stephan, Blankenburg, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541641/ https://www.ncbi.nlm.nih.gov/pubmed/23326754 http://dx.doi.org/10.1155/2012/548157

Ejemplares similares

Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation
por: Hartz, Susanne, et al.
Publicado: (2012)

Dementia Coding, Workup, and Treatment in the VA New England Healthcare System
por: Cho, Kelly, et al.
Publicado: (2014)

Florbetaben for PET Imaging of Beta-Amyloid Plaques in the Brain
por: Richards, Danielle, et al.
Publicado: (2014)

Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study
por: Matías-Guiu, Jordi A., et al.
Publicado: (2015)

(18)F-Florbetaben PET beta-amyloid binding expressed in Centiloids
por: Rowe, Christopher C., et al.
Publicado: (2017)

Early detection of amyloid load using (18)F-florbetaben PET
por: Bullich, Santiago, et al.
Publicado: (2021)

Beta-amyloid imaging with florbetaben
por: Sabri, Osama, et al.
Publicado: (2015)

(18)F–THK–5351, Fluorodeoxyglucose, and Florbetaben PET Images in Atypical Alzheimer’s Disease: A Pictorial Insight into Disease Pathophysiology
por: Park, Sohee, et al.
Publicado: (2021)

Dual-phase (18)F-florbetaben PET provides cerebral perfusion proxy along with beta-amyloid burden in Alzheimer’s disease
por: Yoon, Hai-Jeon, et al.
Publicado: (2021)

Evaluation of early-phase [(18)F]-florbetaben PET acquisition in clinical routine cases
por: Daerr, Sonja, et al.
Publicado: (2016)

(18)F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition
por: Baratto, Lucia, et al.
Publicado: (2018)

Feasibility of in vivo (18)F-florbetaben PET/MR imaging of human carotid amyloid-β
por: Bucerius, Jan, et al.
Publicado: (2017)

Patterns of Focal Amyloid Deposition Using (18)F-Florbetaben PET in Patients with Cognitive Impairment
por: Chung, Sung-eun, et al.
Publicado: (2022)

(18)F-Florbetaben Amyloid PET Imaging: A Chinese Study in Cognitive Normal Controls, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
por: Chang, Yan, et al.
Publicado: (2020)

In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer’s Brain Tissue
por: Ni, Ruiqing, et al.
Publicado: (2021)

FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice
por: Yousefi, Behrooz H, et al.
Publicado: (2015)

The Impact of Amyloid-Beta Positivity with 18F-Florbetaben PET on Neuropsychological Aspects in Parkinson’s Disease Dementia
por: Na, Seunghee, et al.
Publicado: (2020)

Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods
por: Jovalekic, Aleksandar, et al.
Publicado: (2023)

Alzheimer’s Disease Prediction Using Attention Mechanism with Dual-Phase (18)F-Florbetaben Images
por: Kang, Hyeon, et al.
Publicado: (2022)

Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [(18)F]-Florbetaben PET Quantitation in Alzheimer's Model Mice
por: Overhoff, Felix, et al.
Publicado: (2016)

Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents (18)F-flutemetamol and (18)F-florbetaben
por: Son, Hye Joo, et al.
Publicado: (2018)

Optimized dual-time-window protocols for quantitative [(18)F]flutemetamol and [(18)F]florbetaben PET studies
por: Heeman, Fiona, et al.
Publicado: (2019)

Clinical Relevance of [(18)F]Florbetaben and [(18)F]FDG PET/CT Imaging on the Management of Patients with Dementia
por: Librizzi, Damiano, et al.
Publicado: (2021)

Cross-Sectional Comparison of Small Animal [(18)F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models
por: Brendel, Matthias, et al.
Publicado: (2015)

Appropriate reference region selection of (18)F-florbetaben and (18)F-flutemetamol beta-amyloid PET expressed in Centiloid
por: Cho, Soo Hyun, et al.
Publicado: (2020)

Performance evaluation in [(18)F]Florbetaben brain PET images classification using 3D Convolutional Neural Network
por: Lee, Seung-Yeon, et al.
Publicado: (2021)

In vivo Imaging With (18)F-FDG- and (18)F-Florbetaben-PET/MRI Detects Pathological Changes in the Brain of the Commonly Used 5XFAD Mouse Model of Alzheimer's Disease
por: Franke, Timon N., et al.
Publicado: (2020)

Ethnic comparison of pharmacokinetics of (18)F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects
por: Senda, Michio, et al.
Publicado: (2014)

Optimized classification of (18)F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment
por: Bullich, Santiago, et al.
Publicado: (2017)

Correlation of [(18)F]florbetaben textural features and age of onset of Alzheimer’s disease: a principal components analysis approach
por: Li, Jing, et al.
Publicado: (2021)

Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
por: Willuweit, Antje, et al.
Publicado: (2021)

(18)F-florbetaben Aβ imaging in mild cognitive impairment
por: Ong, Kevin, et al.
Publicado: (2013)

A simple and efficient automated microvolume radiosynthesis of [(18)F]Florbetaben
por: Lisova, Ksenia, et al.
Publicado: (2020)

Concordance in detecting amyloid positivity between (18)F-florbetaben and (18)F-flutemetamol amyloid PET using quantitative and qualitative assessments
por: Cho, Soo Hyun, et al.
Publicado: (2020)

Comparison of early F-18 Florbetaben PET/CT to Tc-99m ECD SPECT using voxel, regional, and network analysis
por: Kwon, Soo Jin, et al.
Publicado: (2021)

Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes
por: Kim, Jun Pyo, et al.
Publicado: (2019)

Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening
por: Phillips, Glenn A, et al.
Publicado: (2014)

Generation of Conventional (18)F-FDG PET Images from (18)F-Florbetaben PET Images Using Generative Adversarial Network: A Preliminary Study Using ADNI Dataset
por: Choi, Hyung Jin, et al.
Publicado: (2023)

Author Correction: Concordance in detecting amyloid positivity between (18)F-florbetaben and (18)F-flutemetamol amyloid PET using quantitative and qualitative assessments
por: Cho, Soo Hyun, et al.
Publicado: (2021)

Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination
por: Laudicella, Riccardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ga9c1lnanmh3vr2ct22gn8ps7f